Pasithea Therapeutics Receives AUD $1 Million Research Award Following Recent Acquisition
July 18, 2022 at 11:57 AM EDT
Pasithea Therapeutics Corp. (NASDAQ: KTTA) recently announced the availability of an AUD $1 million (USD $694,000) drug development ...